HomeCompareGENSF vs KMB

GENSF vs KMB: Dividend Comparison 2026

GENSF yields 1.21% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KMB wins by $22.6K in total portfolio value
10 years
GENSF
GENSF
● Live price
1.21%
Share price
$35.97
Annual div
$0.43
5Y div CAGR
13.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.3K
Annual income
$496.41
Full GENSF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — GENSF vs KMB

📍 KMB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGENSFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GENSF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GENSF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GENSF
Annual income on $10K today (after 15% tax)
$102.72/yr
After 10yr DRIP, annual income (after tax)
$421.95/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, KMB beats the other by $4,017.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GENSF + KMB for your $10,000?

GENSF: 50%KMB: 50%
100% KMB50/50100% GENSF
Portfolio after 10yr
$34.6K
Annual income
$2,859.37/yr
Blended yield
8.27%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

GENSF
No analyst data
Altman Z
4.9
Piotroski
7/9
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GENSF buys
0
KMB buys
0
No recent congressional trades found for GENSF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGENSFKMB
Forward yield1.21%5.25%
Annual dividend / share$0.43$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR13.5%17%
Portfolio after 10y$23.3K$45.9K
Annual income after 10y$496.41$5,222.34
Total dividends collected$2.8K$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: GENSF vs KMB ($10,000, DRIP)

YearGENSF PortfolioGENSF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$10,837$137.16$11,314$614.45$477.00KMB
2$11,753$157.68$12,867$760.19$1.1KKMB
3$12,758$181.39$14,713$945.27$2.0KKMB
4$13,859$208.85$16,924$1,181.90$3.1KKMB
5$15,070$240.67$19,596$1,486.64$4.5KKMB
6$16,403$277.60$22,850$1,882.16$6.4KKMB
7$17,872$320.50$26,849$2,399.80$9.0KKMB
8$19,493$370.41$31,812$3,083.36$12.3KKMB
9$21,286$428.56$38,033$3,994.72$16.7KKMB
10$23,272$496.41$45,918$5,222.34$22.6KKMB

GENSF vs KMB: Complete Analysis 2026

GENSFStock

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.

Full GENSF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this GENSF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GENSF vs SCHDGENSF vs JEPIGENSF vs OGENSF vs KOGENSF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.